Indications |
Oral Hepatic diseases Adult: 140 mg bid/tid. |
Contraindications |
Hypersensitivity, pregnancy, lactation. |
Warnings / Precautions |
Children. |
Adverse Reactions |
Occasional laxative effects. Abdominal bloating, diarrhoea, flatulence, loss of appetite, anorexia, nausea, stomach upset. |
Mechanism of Actions |
Silymarin is an active principle from the fruit of Silybum marianum, which contains a mixture of flavonolignans. It reduces the turnover of membrane phospholipids and stabilises the cell membranes of hepatocytes. It has potent antioxidant action and prevents lipid peroxidation. |
Administration |
Should be taken with food. (Take after meals.) |
ATC Classification |
A05BA03 - silymarin ; Belongs to the class of drugs used in liver therapy. |
Available As |
|
Silymarin
Post Review about Silymarin Click here to cancel reply.
Silymarin is used in following diseases
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.